Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Doehn

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Onkologie|November 8, 2003
[Quality of life in urologic oncology: new aspects]C Doehn, D Jocham
Current Opinion in Molecular Therapeutics|March 16, 2001
Technology evaluation: TG-1031, Transgene SAC Doehn, D Jocham
Current Opinion in Molecular Therapeutics|March 16, 2001
Technology evaluation: CN-706, Calydon IncC Doehn, D Jocham
Der Urologe. Ausg. A|September 7, 2002
[Obstruction of the lower urinary tract]D Jocham, C Doehn
Der Urologe. Ausg. A|July 17, 2016
[First-line treatment for advanced renal cell carcinoma : A phase 3, open-label, randomized study of Atezolizumab (Anti-PD-L1-Antibody) in combination with Bevacizumab versus Sunitinib in patients with untreated advanced renal cell carcinoma ("IMmotion") - AN 37/15 der AUO]H Rexer, C Doehn
The Journal of Urology|October 23, 1997
Laparoscopic nephropexy: 3-year experienceP Fornara, C Doehn, D Jocham
International Journal of Urology : Official Journal of the Japanese Urological Association|June 22, 1999
Intra-abdominal abscess due to patient non-compliance after construction of an ileal neobladder: case report and review of the literatureC Doehn, A Böhle, D Jocham
Der Urologe. Ausg. A|May 8, 2002
[Urologic laparoscopy in marginal patients]C Doehn, P Fornara, D Jocham
Aktuelle Urologie|November 27, 2019
H Rexer, C Doehn, A Merseburger
Aktuelle Urologie|August 8, 2012
[Active surveillance for renal cell carcinoma]C Doehn, U Witzsch, M Siebels
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Onkologie|November 8, 2003
[Quality of life in urologic oncology: new aspects]C Doehn, D Jocham
Current Opinion in Molecular Therapeutics|March 16, 2001
Technology evaluation: TG-1031, Transgene SAC Doehn, D Jocham
Current Opinion in Molecular Therapeutics|March 16, 2001
Technology evaluation: CN-706, Calydon IncC Doehn, D Jocham
Der Urologe. Ausg. A|September 7, 2002
[Obstruction of the lower urinary tract]D Jocham, C Doehn
Der Urologe. Ausg. A|July 17, 2016
[First-line treatment for advanced renal cell carcinoma : A phase 3, open-label, randomized study of Atezolizumab (Anti-PD-L1-Antibody) in combination with Bevacizumab versus Sunitinib in patients with untreated advanced renal cell carcinoma ("IMmotion") - AN 37/15 der AUO]H Rexer, C Doehn
The Journal of Urology|October 23, 1997
Laparoscopic nephropexy: 3-year experienceP Fornara, C Doehn, D Jocham
International Journal of Urology : Official Journal of the Japanese Urological Association|June 22, 1999
Intra-abdominal abscess due to patient non-compliance after construction of an ileal neobladder: case report and review of the literatureC Doehn, A Böhle, D Jocham
Der Urologe. Ausg. A|May 8, 2002
[Urologic laparoscopy in marginal patients]C Doehn, P Fornara, D Jocham
Aktuelle Urologie|November 27, 2019
H Rexer, C Doehn, A Merseburger
Aktuelle Urologie|August 8, 2012
[Active surveillance for renal cell carcinoma]C Doehn, U Witzsch, M Siebels
Pageof 9